arcadia biosciences glp-1 receptor agonist weight management diabetes treatments Indications for GLP-1/GIP RA Summary Sheet and Beyond! GLP-1 Receptor Agonists as Treatments
Description
Lancet 2021;397:97184.ArticlePubMed 48
GLP-1 RA offer consistent glycemic control with low potential to cause hypoglycemia
Patients in Ro's study lost an average of 16.6% of their body weight over 68 weeks
This stigma extends to both individuals with obesity and those who are clinically considered lean, with negative evaluations being stronger towards those who lose weight using these medications compared with those making standard lifestyle choices such as in diet and exercise
[DOI] [PubMed] [Google Scholar] 135.Watt K.D., Paul S., Khan M.Q., et al
